Cargando…
Novel Viral Vectored Vaccines for the Prevention of Influenza
Influenza represents a substantial global healthcare burden, with annual epidemics resulting in 3–5 million cases of severe illness with a significant associated mortality. In addition, the risk of a virulent and lethal influenza pandemic has generated widespread and warranted concern. Currently lic...
Autor principal: | Lambe, Teresa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
ScholarOne
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3510293/ https://www.ncbi.nlm.nih.gov/pubmed/22735755 http://dx.doi.org/10.2119/molmed.2012.00147 |
Ejemplares similares
-
Clinical Advances in Viral-Vectored Influenza Vaccines
por: Sebastian, Sarah, et al.
Publicado: (2018) -
Viral vector vaccines
por: McCann, Naina, et al.
Publicado: (2022) -
Viral vector-based influenza vaccines
por: de Vries, Rory D., et al.
Publicado: (2016) -
Vaccination with viral vectors expressing NP, M1 and chimeric hemagglutinin induces broad protection against influenza virus challenge in mice
por: Asthagiri Arunkumar, Guha, et al.
Publicado: (2019) -
Vaccination With Viral Vectors Expressing Chimeric Hemagglutinin, NP and M1 Antigens Protects Ferrets Against Influenza Virus Challenge
por: McMahon, Meagan, et al.
Publicado: (2019)